Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.21
-0.88 (-7.28%)
At close: Jul 18, 2025, 4:00 PM
11.66
+0.45 (4.01%)
After-hours: Jul 18, 2025, 4:52 PM EDT

Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts that cover Nurix Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $29.56, which forecasts a 163.69% increase in the stock price over the next year. The lowest target is $16 and the highest is $41.

Price Target: $29.56 (+163.69%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$16$29.56$30$41
Change+42.73%+163.69%+167.62%+265.74%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy777777
Buy988887
Hold122222
Sell000000
Strong Sell000000
Total171717171716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$17$16
HoldMaintains$17$16+42.73%Jul 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$36$34
Strong BuyMaintains$36$34+203.30%Jul 14, 2025
UBS
UBS
Strong Buy
Maintains
$30$26
Strong BuyMaintains$30$26+131.94%Jul 10, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$32$30
BuyMaintains$32$30+167.62%Jul 10, 2025
Stephens & Co.
Stephens & Co.
Buy
Reiterates
$30
BuyReiterates$30+167.62%Jul 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
73.57M
from 54.55M
Increased by 34.87%
Revenue Next Year
60.71M
from 73.57M
Decreased by -17.49%
EPS This Year
-3.00
from -2.88
EPS Next Year
-3.49
from -3.00
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingNov 30, 2020Nov 30, 2021Nov 30, 2022Nov 30, 2023Nov 30, 2024Nov 30, 2025Nov 30, 2026Nov 30, 2027
Revenue
17.82M29.75M38.63M76.99M54.55M73.57M60.71M81.93M
Revenue Growth
-42.73%66.95%29.84%99.31%-29.15%34.87%-17.49%34.96%
EPS
-2.76-2.73-3.71-2.65-2.88-3.00-3.49-3.31
EPS Growth
--------
Forward PE
--------
No. Analysts
-----202015
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High116.8M99.8M224.5M
Avg73.6M60.7M81.9M
Low18.1Mn/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
114.1%
35.6%
269.9%
Avg
34.9%
-17.5%
35.0%
Low
-66.8%
--

EPS Forecast

EPS20252026202720282029
High-2.14-2.07-1.63
Avg-3.00-3.49-3.31
Low-3.19-4.51-4.17

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.